Members |
targetComponentId |
Cocaine hydrochloride 2.5% conventional release eye solution |
Product containing only cocaine in ocular dose form (medicinal product form) |
Cocaine hydrochloride 2.5% single-use solution |
Product containing only cocaine in ocular dose form (medicinal product form) |
Cocaine hydrochloride 4% topical solution |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
Cocaine viscous 10% conventional release cutaneous solution |
Product containing only cocaine (medicinal product) |
Cocaine viscous 10% topical solution |
Product containing only cocaine (medicinal product) |
Cocaine viscous 4% conventional release cutaneous solution |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
Cocaine viscous 4% topical solution |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
Cocaine+epinephrine 5%/0.02% eye drops |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
Cocaine+homatropine 2%/2% eye drops |
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
Cochleo-orbicular reflex |
Auropalpebral reflex finding |
Coconut - dietary |
Coconut (substance) |
Cod - dietary |
Cod (substance) |
Codeine phosphate + promethazine hydrochloride 10mg/6.25mg syrup |
Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
Codeine phosphate+kaolin 10mg/3g/10mL mixture |
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Coelenterate |
Phylum Cnidaria (organism) |
Coenzyme-A transferase |
Coenzyme-A transferase |
Coffee compliment |
Beverage whiteners |
Cognitive impairment caused by ingestible alcohol |
Cognitive impairment caused by ethanol (disorder) |
Cohabitee in relationship with subject |
Cohabitee (person) |
Coital sexual orgasm |
Coital sexual orgasm (finding) |
Cold environment |
Cold environment |
Colestyramine+aspartame 4g/sachet conventional release oral powder |
Product containing only colestyramine (medicinal product) |
Colestyramine+aspartame 4g/sachet s/f oral powder |
Product containing only colestyramine (medicinal product) |
Colestyramine+aspartame 4g/sachet s/f oral powder |
Product containing only colestyramine (medicinal product) |
Colfosceril palmitate 108mg sterile powder for suspension |
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheopulmonary instillation (clinical drug) |
Colistimethate sodium 1million international units powder for nebulization |
Colistimethate 40 mg/mL solution for inhalation |
Colistin sulfate 1.5million units tablet |
Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug) |
Colitoxemia |
Sepsis |
Colitoxicosis |
Sepsis |
Collagen disease NOS |
Collagen disease |
Collagen disease NOS |
Collagen disease |
Collagen punctal plug |
Collagen punctal plug (physical object) |
Collagenase agent |
Collagenase |
Collapse of vertebra due to osteoporosis NOS |
Osteoporotic vertebral collapse |
Collapse of vertebra due to osteoporosis NOS |
Osteoporotic vertebral collapse |
Collapsed vertebra NOS |
Collapse of vertebra |
Collapsed vertebra NOS |
Collapse of vertebra |
Collection of 24-hour urine specimen for laboratory |
Urine specimen collection, 24 hours |
Collection of specimen by nursing |
Specimen collection |
Collier's stripes |
Collier's stripes (finding) |
Collision of aircraft with other object, while in transit |
Accident to powered aircraft |
Collision of aircraft with other object, while in transit |
Accident to powered aircraft |
Colon flap |
Flap (substance) |
Colon/rectum TNM finding |
American Joint Committee on Cancer allowable value |
Colonic gland |
Colonic crypt of Lieberkühn |
Colonna osteotomy for congenital deformity of hip |
Colonna arthroplasty (procedure) |
Colonoscopy equivocal |
Colonoscopy equivocal (finding) |
Colony-forming unit |
Stem cell colony-forming unit |
Colony-forming unit, basophil |
Colony-forming unit of basophilic lineage (cell) |
Colony-forming unit, blast |
Blast colony-forming unit (cell) |
Colony-forming unit, diffusion chamber |
Diffusion chamber colony-forming unit (cell) |
Colony-forming unit, eosinophil |
Colony-forming unit of eosinophilic lineage (cell) |
Colony-forming unit, erythroid |
Colony-forming unit of erythroid lineage (cell) |
Colony-forming unit, granulocyte |
Colony-forming unit of granulocytic lineage (cell) |
Colony-forming unit, granulocyte-erythroid-macrophage-megakaryocyte |
Colony-forming unit of granulocytic-erythroid-macrophagocytic-megakaryocytic lineage (cell) |
Colony-forming unit, granulocyte-macrophage |
Colony-forming unit of granulocytic-macrophagocytic lineage (cell) |
Colony-forming unit, granulocyte-monocyte |
Colony-forming unit of granulocytic-monocytic lineage (cell) |
Colony-forming unit, lymphoid-myeloid |
Colony-forming unit of lymphoid-myeloid lineage (cell) |
Colony-forming unit, macrophage |
Colony-forming unit of macrophagocytic lineage (cell) |
Colony-forming unit, megakaryocyte |
Colony-forming unit of megakarocytic lineage (cell) |
Colony-forming unit, monocyte |
Colony-forming unit of monocytic lineage (cell) |
Colony-forming unit, neutrophil-monocyte |
Colony-forming unit of neutrophilic-monocytic lineage (cell) |
Colony-forming unit, spleen |
Spleen colony-forming unit (cell) |
Colony-stimulating factor, megakaryocyte |
Thrombopoietin |
Color symptom |
Finding of color of skin |
Color symptom NOS |
Finding of color of skin |
Colorado tick fever virus subgroup |
Colorado tick fever virus |
Colostomy NEC |
Colostomy (procedure) |
Colour symptom |
Finding of color of skin |
Colour symptom NOS |
Finding of color of skin |
Colubrid snake |
Family Colubridae - colubrid |
Columba fasciata |
Patagioenas fasciata (organism) |
Columnar cell papilloma uncertain whether benign or malignant |
Oncocytic Schneiderian papilloma of uncertain behavior (morphologic abnormality) |
Comb-footed spider |
Family Theridiidae (organism) |
Combined X-ray therapy |
X-ray beam therapy |
Combined X-ray therapy |
X-ray beam therapy |
Combined abdominal and vaginal operation to support outlet of female bladder NOS |
Operation on neck of urinary bladder for female stress incontinence |
Combined abdominal and vaginal operations to support outlet of female bladder |
Operation on neck of urinary bladder for female stress incontinence |
Combined antituberculosis drug |
Antituberculosis agent |
Combined drug dependence, continuous |
Combined substance dependence, continuous |
Combined drug dependence, excluding opioid, NOS |
Combined substance dependence, excluding opioids (disorder) |
Combined drug dependence, excluding opioid, continuous |
Combined substance dependence, excluding opioid, continuous |
Combined drug dependence, excluding opioid, episodic |
Combined substance dependence, excluding opioid, episodic |
Combined drug dependence, excluding opioid, in remission |
Combined substance dependence, excluding opioid, in remission (disorder) |
Combined drug dependence, excluding opioid, unspecified |
Combined substance dependence, excluding opioids (disorder) |
Combined drug dependence, excluding opioids |
Combined substance dependence, excluding opioids (disorder) |
Combined fast-electron therapy |
Fast-electron therapy |
Combined fast-electron therapy |
Fast-electron therapy |
Combined hamartoma of retina |
A rare benign eye tumor characterized by the presence of glial cells, vascular tissue, and sheets of pigment epithelial cells lacking the distribution and organization of the normal retina and retinal pigment epithelium. The lesion is most commonly found unilaterally as a slightly elevated mass in a peripapillary location but can also occur in the macula or the retinal periphery. It is sometimes associated with neurofibromatosis type 1 or 2, nevoid basal cell carcinoma syndrome, or branchio-oculo-facial syndrome. Patients may be asymptomatic or present with progressive loss of vision. |
Combined heavy particle therapy |
External beam radiation therapy particulate radiation (procedure) |
Combined heavy particle therapy |
External beam radiation therapy particulate radiation (procedure) |
Combined internal radiotherapy |
Radionuclide therapy |
Combined internal radiotherapy |
Radionuclide therapy |
Combined opioid with non-opioid drug dependence |
Combined opioid with non-opioid substance dependence |
Combined opioid with non-opioid drug dependence in remission |
Combined opioid with non-opioid substance dependence in remission |
Combined opioid with non-opioid drug dependence, continuous |
Combined opioid with non-opioid substance dependence, continuous (disorder) |
Combined opioid with non-opioid drug dependence, episodic |
Combined opioid with non-opioid substance dependence, episodic |
Combined opioid with other drug dependence NOS |
Combined opioid with non-opioid substance dependence |
Combined opioid with other drug dependence, unspecified |
Combined opioid with non-opioid substance dependence |
Combined photon therapy |
High-energy beam therapy (procedure) |
Combined photon therapy |
High-energy beam therapy (procedure) |